Foundation Medicine, Inc.
FMI
FMI was delisted on the 30th of July, 2018.
157 hedge funds and large institutions have $1.86B invested in Foundation Medicine, Inc. in 2018 Q2 according to their latest regulatory filings, with 54 funds opening new positions, 44 increasing their positions, 38 reducing their positions, and 41 closing their positions.
133% more funds holding in top 10
Funds holding in top 10: 3 → 7 (+4)
88% more capital invested
Capital invested by funds: $986M → $1.86B (+$871M)
66% more call options, than puts
Call options by funds: $87.8M | Put options by funds: $52.8M
32% more first-time investments, than exits
New positions opened: 54 | Existing positions closed: 41
16% more repeat investments, than reductions
Existing positions increased: 44 | Existing positions reduced: 38
9% more funds holding
Funds holding: 144 → 157 (+13)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
JP Morgan Chase
New York
|
+$33.2M |
| 2 |
BCM
Beryl Capital Management
Redondo Beach,
California
|
+$31.2M |
| 3 |
Vanguard Group
Malvern,
Pennsylvania
|
+$29.9M |
| 4 |
GF
Gabelli Funds
Rye,
New York
|
+$26.6M |
| 5 |
Morgan Stanley
New York
|
+$24.5M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
OC
Oppenheimer & Co
New York
|
-$63.6M |
| 2 |
Lord, Abbett & Co
Jersey City,
New Jersey
|
-$48.3M |
| 3 |
HCM
Hitchwood Capital Management
New York
|
-$31.5M |
| 4 |
AAMU
Amundi Asset Management US
Boston,
Massachusetts
|
-$21.6M |
| 5 |
AllianceBernstein
Nashville,
Tennessee
|
-$13.9M |
FMI Hedge Fund Activity: Q2 2018 in Review
157 of the 4,368 institutional investors tracked by Wall St. Rank reported a position in Foundation Medicine, Inc. (FMI) for Q2 2018, worth a combined $1.86B — up 88% from $986M a quarter earlier.
Buyers outnumbered sellers: 54 funds opened new FMI positions and 41 closed out — a net gain of 13 holders — while 44 added to existing stakes and 38 trimmed.
The largest buyer was JP Morgan Chase, adding an estimated $33.2M. The largest seller was Oppenheimer & Co, cutting an estimated $63.6M.
- 157 institutional investors held Foundation Medicine, Inc. (FMI) as of Q2 2018, up from 144 in Q1 2018.
- Funds reported $1.86B of Foundation Medicine, Inc. stock for Q2 2018, up 88% quarter-over-quarter.
- 54 funds opened new Foundation Medicine, Inc. positions in Q2 2018 and 41 closed out, a net change of +13 holders.
- The largest Foundation Medicine, Inc. buyer in Q2 2018 was JP Morgan Chase, an estimated $33.2M added.
- The largest Foundation Medicine, Inc. seller in Q2 2018 was Oppenheimer & Co, an estimated $63.6M sold.
Based on aggregated 13F filings for Q2 2018.